Is intracavernosal corticosteroid infiltration really useless in Peyronies disease?
The value of intracavernosal corticosteroid infiltration remains controversial or may even be contraindicated in Peyronie’s disease, as it is considered to be ineffective and a source of morbidity. OBJECTIVE: To retrospectively analyse the efficacy and safety of intracavernosal corticosteroid infiltration in a selected population only presenting clinical criteria of the acute phase of Peyronie’s disease (pain and/or recent onset < 6 months). MATERIAL AND METHOD: Intracavernosal corticosteroid infiltration (weekly or twice-weekly) was performed in or around the plaque. Evaluation was based on clinical criteria according to the course of pain, the nodule and curvature and the rates of improvement, resolution, stabilization and deterioration of these criteria were studied. RESULTS: In a series of 271 patients, 123 presented criteria of the acute phase of Peyronie's disease. Forty five of these patients were treated exclusively by intracavernosal corticosteroid infiltration. The mean age w
